Frequent coauthors
- OHSHIMA ETSUO 78
- WATANABE AKIHIKO 78
- KIMOTO NAOYA 65
- MIYAKE KIYOMI 13
- WATANABE AKIKO 13
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.
The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
It is intended to provide a remedy for endometriosis which contains an interleukin-5 antagonist as the active ingredient.